Skip to main content
Signal8
Launch Terminal
NEIS JOHN profile photo

John Neis

CIK: 0001167426

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cellectar Biosciences, Inc. logo
CLRB

Cellectar Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Jul 7, 2026
    Award(A)

    Stock option (right to buy)

    Direct
    25K shares-
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Dec 12, 2025
    Sale(S)
    Indirect
    198 shares at avg. $3.70$731.986
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Feb 14, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    60K shares-

1-3 of 3

About NEIS JOHN

NEIS JOHN (SEC CIK 0001167426) files insider reports with the SEC as Director of Cellectar Biosciences, Inc. (CLRB).

Signal8 holds 3 ownership filings by NEIS JOHN, all Form 4s, filed between Feb 18, 2025 and Jul 8, 2026. Those filings report 3 transactions, from Feb 14, 2025 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on NEIS JOHN's filings is in FLORHAM PARK, NJ.

Recent filings by NEIS JOHN

  • Jul 7, 2026: Grant or award of CLRB derivative securities (Form 4, code A).
  • Dec 12, 2025: Open-market sale of CLRB shares (Form 4, code S).
  • Feb 14, 2025: Grant or award of CLRB derivative securities (Form 4, code A).

Other insiders filing for Cellectar Biosciences, Inc. (CLRB)

How to read Form 4 transaction codes